K. Deres

发表

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.

K. Schlemmer, S. Wohlfeil, A. Paessens, 2002, Antiviral research.

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast

H. Rammensee, O. Rötzschke, G. Jung, 1991, The Journal of experimental medicine.

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

Hans-Georg Rammensee, Jörg Metzger, H. Rammensee, 1990, Nature.

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

H. Rammensee, H. Schild, K. Wiesmüller, 1989, Nature.

Ceramide‐independent CD28 and TCR signaling but reduced IL‐2 secretion in T cells of acid sphingomyelinase‐deficient mice

Michael Nix, K. Deres, B. Stoffel, 1998, European journal of immunology.

Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells

H. Schild, K. Wiesmüller, G. Jung, 1991, European journal of immunology.

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

B. Beckermann, U. Pleiss, K. Schlemmer, 2003, Science.

Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.

H. Hacker, C. Schröder, M. Mildenberger, 2003, Biochemical pharmacology.

Development of resistance and perspectives for future therapies against hepatitis B infections: Lessons to be learned from HIV

H. Rübsamen-Waigmann, K. Deres, 2007, Infection.

Viral Infections and Treatment

R. Welker, H. Rübsamen-Waigmann, G. Hewlett, 2003 .

Hepatitis B Virus Nucleocapsids Formed by Carboxy-Terminally Mutated Core Proteins Contain Spliced Viral Genomes but Lack Full-Size DNA

H. Blum, F. von Weizsäcker, J. Köck, 2004, Journal of Virology.

Preferred size of peptides that bind to H‐2 Kb is sequence dependent

Georg Greiner, S. Stevanović, T. Schumacher, 1992, European journal of immunology.

Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide

H. Rammensee, H. Schild, K. Wiesmüller, 1991, The Journal of experimental medicine.

Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules

T. Schumacher, H. Ploegh, S. Nathenson, 1992, European journal of immunology.

MHC/peptide binding studies indicate hierarchy of anchor residues.

H. Rammensee, G. Jung, W. Beck, 1993, Cellular immunology.

Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.

H. Rammensee, T. Boon, H. Wallny, 1992, International immunology.

Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization.

W. Bessler, K. Wiesmüller, G. Jung, 1994, Biological chemistry Hoppe-Seyler.

Minimal structure of lipopeptides for in vivo priming of cytotoxic T-lymphocytes

H. Rammensee, H. Schild, G. Jung, 1991 .